Citadel Advisors
STTK icon

Citadel Advisors’s Shattuck Labs STTK Stock Holding History

Citadel Advisors’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,200
Closed -$53.1K – 14026
2025
Q3 		$53.1K Sell
22,200
-13,800
-38% -$16.9K ﹤0.01% 12167
2025
Q2 		$28.5K Buy
+36,000
New +$34.9K ﹤0.01% 12003
2024
Q4 		– Sell
-300
Closed -$1.05K – 15358
2024
Q3 		$1.05K Sell
300
-2,800
-90% -$10.4K ﹤0.01% 13913
2024
Q2 		$12K Sell
3,100
-12,800
-81% -$104K ﹤0.01% 13005
2024
Q1 		$142K Sell
15,900
-3,900
-20% -$35.7K ﹤0.01% 10840
2023
Q4 		$141K Buy
19,800
+19,100
+2,729% +$52.1K ﹤0.01% 10476
2023
Q3 		$1.06K Buy
+700
New +$1.6K ﹤0.01% 13925
2023
Q2 		– Sell
-4,600
Closed -$13.5K – 15210
2023
Q1 		$13.5K Buy
4,600
+4,400
+2,200% +$15.6K ﹤0.01% 13359
2022
Q4 		$460 Buy
+200
New +$501 ﹤0.01% 14650

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Citadel Advisors's STTK Position: Q1 2026 in Review

Citadel Advisors increased its Shattuck Labs (STTK) stake by 115% in Q1 2026, buying an estimated $376K and bringing the position to 148,021 shares worth $952K. The position accounts for ﹤0.01% of the portfolio, ranked #7770.

Citadel Advisors first reported a position in STTK in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.52M in Q4 2021. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • Citadel Advisors held 148,021 shares of Shattuck Labs worth $952K as of Q1 2026.
  • Citadel Advisors bought 79,175 Shattuck Labs shares in Q1 2026, an estimated $376K.
  • Shattuck Labs made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7770 holding.
  • Citadel Advisors first reported a position in Shattuck Labs in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Shattuck Labs position peaked at $1.52M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.